Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
3.200
-0.020 (-0.62%)
At close: Aug 14, 2026, 4:00 PM EDT
3.190
-0.010 (-0.31%)
After-hours: Aug 14, 2026, 7:16 PM EDT
Silo Pharma Revenue
Silo Pharma had revenue of $18.03K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $72.10K. In the year 2025, Silo Pharma had annual revenue of $72.10K.
Revenue (ttm)
$72.10K
Revenue Growth
n/a
P/S Ratio
74.12
Revenue / Employee
$18,026
Employees
3
Market Cap
4.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.10K | - | - |
| Dec 31, 2024 | 72.10K | - | - |
| Dec 31, 2023 | 72.10K | - | - |
| Dec 31, 2022 | 72.10K | 838.00 | 1.18% |
| Dec 31, 2021 | 71.26K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Curis | 7.06M |
| HCW Biologics | 6.59M |
| PMGC Holdings | 1.27M |
| SciSparc | 856.00K |
| Alaunos Therapeutics | 3.00K |
SILO News
- 6 days ago - Silo Pharma granted European patent covering PTSD therapy - TheFly
- 10 days ago - Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - GlobeNewsWire
- 22 days ago - Silo Pharma files to sell 1.91M shares of common stock for holders - TheFly
- 26 days ago - Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program - GlobeNewsWire
- 4 weeks ago - Silo Pharma subsidiary QwikAgents joins AMD AI program - TheFly
- 4 weeks ago - Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform - GlobeNewsWire
- 5 weeks ago - Silo Pharma prices $11.7M at-the-market offering at $6.45 per share - TheFly
- 5 weeks ago - Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire